Plasma cerebellin levels in patients with central serous chorioretinopathy

被引:1
|
作者
Kobat, S. Gungor [1 ]
Yusufoglu, E. [1 ]
Gul, F. C. [1 ]
Celik, F. [1 ]
Kalayci, M. [2 ]
机构
[1] Elazig Hlth Sci Univ, Dept Ophthalmol, Elazig, Turkey
[2] Elazig Hlth Sci Univ, Dept Biochem, Elazig, Turkey
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2021年 / 44卷 / 02期
关键词
Central serous chorioretinopathy; cerebellin; cortisol; adrenaline; noradrenaline; OPTICAL COHERENCE TOMOGRAPHY; IN-VITRO; SECRETORY ACTIVITY; CORTICOSTEROIDS; PATHOGENESIS; UPDATE; RAT;
D O I
10.1016/j.jfo.2020.02.034
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. - To evaluate levels of plasma cerebellin, cortisol, adrenaline and noradrenaline in patients with central serous chorioretinopathy (CSC). Materials and Methods. - This prospective study included 30 patients diagnosed with acute CSC (Group 1) and a control group of 30 age-matched, healthy subjects without CSC (Group 2). Levels of plasma cerebellin, cortisol, adrenaline and noradrenaline were examined in blood samples taken after 8-12 hours of fasting. A value of p < 0.05 was considered statistically significant in the comparative analyses. Results. - The mean plasma cerebellin level was found to be 232.56 +/- 113.28 pg/ml in Group 1 and 174.07 +/- 82.04 pg/ml in Group 2 (p = 0.02). Mean plasma cortisol was 13.19 +/- 3.87 mu g/ml in Group 1 and 9.55 +/- 2.92 mu g/ml in Group 2 (p < 0.01). Mean plasma adrenaline was 60.62 +/- 26.67 pg/ml in Group 1 and 46.17 +/- 19.20 pg/ml in Group 2 (p = 0.03). Mean plasma noradrenaline was 206.66 +/- 73.90 pg/ml in Group 1 and 149.96 +/- 51.36 pg/ml in Group 2 (p < 0.01). Conclusion. - It can be concluded that increased cerebellin may have a role in the etiology of CSC by increasing catecholamine expression from the adrenal medulla and indirectly by increasing cortisol levels via a paracrine effect from the adrenal cortex. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 50 条
  • [31] Choroidal Vascular Reactivity in Central Serous Chorioretinopathy
    Piccolino, Felice Cardillo
    Lupidi, Marco
    Cagini, Carlo
    Fruttini, Daniela
    Nicolo, Massimo
    Eandi, Chiara Maria
    Tito, Silvia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (10) : 3897 - 3905
  • [32] Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment
    Nicholson, Benjamin
    Noble, Jason
    Forooghian, Farzin
    Meyerle, Catherine
    SURVEY OF OPHTHALMOLOGY, 2013, 58 (02) : 103 - 126
  • [33] Cytokine levels of the aqueous humour in central serous chorioretinopathy
    Jung, Sang Hoon
    Kim, Kyung-A
    Sohn, Sea Woon
    Yang, Sung Jae
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2014, 97 (03) : 264 - 269
  • [34] Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy
    Karska-Basta, Izabella
    Pociej-Marciak, Weronika
    Chrzaszcz, Michal
    Kubicka-Trzaska, Agnieszka
    Debicka-Kumela, Magdalena
    Gawecki, Maciej
    Romanowska-Dixon, Bozena
    Sanak, Marek
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 15
  • [35] Central serous chorioretinopathy
    Wang, Maria
    Munch, Inger Christine
    Hasler, Pascal W.
    Pruente, Christian
    Larsen, Michael
    ACTA OPHTHALMOLOGICA, 2008, 86 (02) : 126 - 145
  • [36] EVALUATION OF RETINAL VESSEL DIAMETERS IN EYES WITH ACTIVE CENTRAL SEROUS CHORIORETINOPATHY
    Altunel, Orhan
    Arifoglu, Hasan Basri
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (04): : 861 - 866
  • [37] Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy
    Kim, Y. T.
    Kang, S. W.
    Bai, K. H.
    EYE, 2011, 25 (12) : 1635 - 1640
  • [38] Oxidative stress parameters and antioxidant enzyme levels in patients with central serous chorioretinopathy
    Urfalioglu, S. U.
    Baylan, F. Alkan
    Guler, M.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2021, 24 (01) : 64 - 68
  • [39] Low luminance visual acuity in patients with central serous chorioretinopathy
    Fujita, Kyoko
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Imamura, Yutaka
    Mizutani, Yoshihiro
    Tanaka, Etsuko
    Mizota, Atsushi
    Oda, Koichi
    Yuzawa, Mitsuko
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2013, 96 (01) : 100 - 105
  • [40] Effects of propranolol in patients with central serous chorioretinopathy
    Kianersi, Farzan
    Fesharaki, Farnaz
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2008, 13 (03): : 103 - 107